United Kingdom· GB-APID-38079911000001105
Mayzent 0.25mg tablets
A siponimod product containing siponimod, registered in United Kingdom by Novartis Pharmaceuticals UK Ltd. The same ATC class is registered in 12 of our 19 countries.
Checked against NHS dm+d (United Kingdom) on
Informational only — not a medical device.
Where it is registered
Siponimod is registered in 12 of 19 countries.
Countries holding a registration under ATC L04AE03 (siponimod), each read from that country’s own register.
- This record: United Kingdom, from NHS dm+d (United Kingdom)
- 8 of them publish a price we can compare per daily dose
Siponimod · ATC L04AE03
12 / 19 countries
- Belgiumprice
- Canada
- Czechiaprice
- Denmark
- Finlandprice
- Icelandprice
- Italyprice
- Netherlands
- Polandprice
- Switzerlandprice
- United Kingdom
- United Statesprice
Price per daily dose
What a daily dose of siponimod costs, country by country.
Normalised to the WHO defined daily dose (2 mg), so markets compare like for like.
- 2 markets with a comparable price for this class
- Public list prices, converted to USD at the rate date shown
Siponimod · price per daily dose (2 mg)
USD · FX 28 Sept 2026
- IT Italy$120.54
- CH Switzerland$118.82
The record
At a glance
NHS dm+d (United Kingdom)- Active substance
- Siponimod
- Manufacturer
- Novartis Pharmaceuticals UK Ltd
- Country
- United Kingdom (GB)
- ATC code
- L04AE03
- ATC class
- Siponimod
- Defined daily dose
- 2 mg, O
- Reimbursed
- Not published by this register
- Source register
- NHS dm+d (United Kingdom)
- Last checked
- September 13, 2026
Packs & prices · 4
- gtin07613421023959
- gtin07613421023966
- gtin7613421025342
- gtin7613421023966
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Interactions
667 interactions on record for siponimod.
Graded by severity as the source publishes them — 597 severe. Severity grades are free for everyone; mechanism and management come with Growth.
- Severity for every pair — free, no plan needed
- The source, licence and sync date on every record
- Mechanism and what to do for each pair — Growth plan
Siponimod · interactions on record
667 records
- 597 severe
- 66 moderate
- 4 minor
Most severe, free to view
- CimetidineA02BA01severe
- RanitidineA02BA02severe
- FamotidineA02BA03severe
- NizatidineA02BA04severe
- Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.
Same medicine, other countries
Siponimod in 11 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- CanadaMAYZENTNOVARTIS PHARMACEUTICALS CANADA INC
- United StatesMAYZENTNovartis Pharmaceuticals Corporation
- SwitzerlandMayzent 0.25 mg, FilmtablettenNovartis Pharma Schweiz AG
- FinlandMayzentNovartis Europharm Limited
- IcelandMayzentNovartis Europharm Limited*
- ItalyMAYZENT*12 cpr rivestite 0,25 mgNOVARTIS EUROPHARM LTD
- SpainMAYZENT 0,25 MG COMPRIMIDOS RECUBIERTOS CON PELICULANovartis Europharm Limited
- NetherlandsMayzent 0,25 mg, filmomhulde tablettenNovartis Europharm Limited
Authorised across Europe · EMA
The same active substance is authorised in 3 EEA countries. Names it is sold under:
- Iceland · Mayzent
- Liechtenstein · Mayzent
- Norway · Mayzent
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of NHS dm+d (United Kingdom). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/1cc25eb4-680d-490e-910d-5b1c5f2ce609 GET /v1/drugs/1cc25eb4-680d-490e-910d-5b1c5f2ce609?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"apid": "38079911000001105",
"desc": "Mayzent 0.25mg tablets (Novartis Pharmaceuticals UK Ltd)",
"form": "Oral tablet",
"vpid": "38096911000001109",
"source": "dmd",
"vtm_id": "787020007",
"strength": "250 microgram",
"substance": "Siponimod",
"ingredient": "Siponimod fumaric acid",
"supplier_code": "2920101000001102"
}See everything about siponimod.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.